About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 342   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Update on clinical trials in dry Age-related macular degeneration

Taskintuna Ibrahim, Elsayed M.E. A. Abdalla, Schatz Patrik

Year : 2016| Volume: 23| Issue : 1 | Page no: 13-26

   This article has been cited by
1 Platelet Lysate as a Promising Medium for Nanocarriers in the Management and Treatment of Ocular Diseases
S. Balaji, R. Karthikeyan, V. Kiran, B. Yuvaraj, Saraswathi Nagaraj, Sivakami Manivannan, Shoba Narayan
Current Ophthalmology Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model
Soo-Young Kim, Siva P. Kambhampati, Imran A. Bhutto, D. Scott McLeod, Gerard A. Lutty, Rangaramanujam M. Kannan
Experimental Eye Research. 2021; 203: 108391
[Pubmed]  [Google Scholar] [DOI]
3 Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage
Balasubramaniam Annamalai, Nathaniel Parsons, Crystal Nicholson, Elisabeth Obert, Bryan Jones, Bärbel Rohrer
Investigative Opthalmology & Visual Science. 2021; 62(4): 11
[Pubmed]  [Google Scholar] [DOI]
4 Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration
Keng Siang Lee, Shuxiao Lin, David A. Copland, Andrew D. Dick, Jian Liu
Journal of Neuroinflammation. 2021; 18(1)
[Pubmed]  [Google Scholar] [DOI]
5 Progress in the Treatment of Dry Age-Related Macular Degeneration
?? ?
Advances in Clinical Medicine. 2020; 10(05): 849
[Pubmed]  [Google Scholar] [DOI]
6 Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, Jing-Ping Liou
Journal of Medicinal Chemistry. 2020; 63(19): 10533
[Pubmed]  [Google Scholar] [DOI]
7 A Semiautomated, Phenotypic, In Vitro Scratch Assay for Assessing Retinal Pigment Epithelial Cell Wound Healing
Tina Storm, Iain Wilson, Ross Campbell, Arantxa Bolinches-Amorós, Angela J. Russell, Stephen G. Davies, Alun R. Barnard, Robert E. MacLaren
Journal of Ocular Pharmacology and Therapeutics. 2020; 36(4): 257
[Pubmed]  [Google Scholar] [DOI]
8 A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
Eun-Jeong Choi, Go-Wun Choi, Ju Hee Kim, Hee-Woon Jang, Ju-Hee Lee, Hyun Ju Bae, Young Gwan Kim, Yong-Bok Lee, Hea-Young Cho
Molecules. 2020; 25(3): 663
[Pubmed]  [Google Scholar] [DOI]
9 Ocular Carotenoid Status in Health and Disease
Lydia Sauer, Binxing Li, Paul S. Bernstein
Annual Review of Nutrition. 2019; 39(1): 95
[Pubmed]  [Google Scholar] [DOI]
10 Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients
Janan Arslan, Paul N Baird
Pharmacogenomics. 2018; 19(5): 435
[Pubmed]  [Google Scholar] [DOI]
11 Lessons from Anti-Amyloid-ß Immunotherapies in Alzheimer Disease: Aiming at a Moving Target
Youmei Wang, Tao Yan, Honghui Lu, Weiming Yin, Bin Lin, Weibin Fan, Xiaoli Zhang, Pedro Fernandez-Funez
Neurodegenerative Diseases. 2017; 17(6): 242
[Pubmed]  [Google Scholar] [DOI]


Read this article